2020版梅尼埃病临床实践指南解读

Interpretation of clinical practice guideline:Ménière’s disease(2020)

梅尼埃病是一种病因不明的临床综合征。1861年,Ménière首先报道了内耳(膜迷路)病变可能是表现为发作性眩晕、耳鸣和听力损失的综合征的根源[1]。目前有关梅尼埃病发病率和患病率的文献报道在不同国家、地区和人种之间均存在较大差异,2020年美国耳鼻咽喉头颈外科学会(American Academy of Otolaryngology-Head and Neck Surgery Foundation,AAO-HNS)报道梅尼埃病的患病(50~200)/10万,最常见于40~60岁[2-4]。

In 1972,the Committee on Hearing and Equilibrium of the American Academy of Otoaryngology(AAO-CHE)produced the first diagnostic guidelines for Ménière’s disease.The American Academy of Otolaryngology-Head and Neck Surgery Foundation(AAO-HNS)modified them in 1985,1995 and 2015.Then,AAO-HNS developed the latest updated version of the Ménière’s Disease Guidelines in 2020,based on the latest evidence-based medicine foundation.In this paper,the overall framework and key content of the latest guideline in 2020 are interpreted for domestic colleagues.